MYSTY CHACKO: Open Payments
NPI 1669003745 · MOORESTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,245 in 96 payments from 12 companies in 2025. Trend: 2023 $1,164 · 2024 $6,259 · 2025 $2,245
Food & beverage: $2,245
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $501 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $402 |
| Ardelyx, Inc. | 24 | $318 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 11 | $280 |
| Janssen Biotech, Inc. | 5 | $227 |
| Celltrion USA Inc. | 6 | $199 |
| GENZYME CORPORATION | 4 | $144 |
| Regeneron Healthcare Solutions, Inc. | 4 | $70 |
| Novo Nordisk Inc | 1 | $35 |
| PFIZER INC. | 2 | $34 |
Products named: ENTYVIO, IBSRELA, XIFAXAN, TREMFYA, DUPIXENT, RINVOQ, ZYMFENTRA, VEGZELMA.
Industry payments across NJ — which companies pay providers there.
